메뉴 건너뛰기




Volumn 90, Issue 1, 1996, Pages 45-48

Therapy-related leukemia with a novel 21q22 rearrangement

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; MITOXANTRONE; PROCARBAZINE;

EID: 0030220292     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/0165-4608(96)00044-1     Document Type: Article
Times cited : (7)

References (15)
  • 1
    • 0025059007 scopus 로고
    • Acute myelogenous leukemia with an 8;21 translocation
    • Groupe Français de Cytogénétique Hématologique (1990): Acute myelogenous leukemia with an 8;21 translocation. Cancer Genet Cytogenet 44:169-179.
    • (1990) Cancer Genet Cytogenet , vol.44 , pp. 169-179
  • 2
    • 0027218725 scopus 로고
    • The t(8;21) translocation in acute myeloid leukemia results in production of AML1-MTG8 fusion transcript
    • Miyoshi H, Kozu T, Shimizu K, Enomoto K, Maseki N, Kaneko Y, Kamada N, Ohki M (1993): The t(8;21) translocation in acute myeloid leukemia results in production of AML1-MTG8 fusion transcript. EMBO) 12:2715-2721.
    • (1993) EMBO , vol.12 , pp. 2715-2721
    • Miyoshi, H.1    Kozu, T.2    Shimizu, K.3    Enomoto, K.4    Maseki, N.5    Kaneko, Y.6    Kamada, N.7    Ohki, M.8
  • 4
    • 0028326283 scopus 로고
    • The balanced and the unbalanced chromosome aberrations of acute myeloid leukemia may develop in different ways and may contribute differently to malignant transformation
    • Pedersen-Bjergaard J, Rowley JD (1994): The balanced and the unbalanced chromosome aberrations of acute myeloid leukemia may develop in different ways and may contribute differently to malignant transformation. Blood 83:2780-2786.
    • (1994) Blood , vol.83 , pp. 2780-2786
    • Pedersen-Bjergaard, J.1    Rowley, J.D.2
  • 5
    • 0026584519 scopus 로고
    • Leukemia and myelodysplastic syndromes secondary to drag, radiation, and environmental exposure
    • Levine EG, Bloomfield CD (1992): Leukemia and myelodysplastic syndromes secondary to drag, radiation, and environmental exposure. Semin Oncol 19:47-84.
    • (1992) Semin Oncol , vol.19 , pp. 47-84
    • Levine, E.G.1    Bloomfield, C.D.2
  • 6
    • 0024469383 scopus 로고
    • Cytogenetics and their prognostic value in de novo acute myeloid leukemia: A report on 283 cases
    • Fenaux P, Preudhomme C, Laï JL, Morel P, Beuscart R, Bauters F (1989): Cytogenetics and their prognostic value in de novo acute myeloid leukemia: A report on 283 cases. Br J Haematol 73:61-67.
    • (1989) Br J Haematol , vol.73 , pp. 61-67
    • Fenaux, P.1    Preudhomme, C.2    Laï, J.L.3    Morel, P.4    Beuscart, R.5    Bauters, F.6
  • 8
    • 0025689037 scopus 로고
    • T(3;21) (q26;q22): A recurring chromosomal abnormality in therapy-related myelodysplastic syndrome and acute myeloid leukemia
    • Rubin CM, Larson RA, Anastasi J, Winter JN, Thangalevu M, Vardiman JW, Rowley JD, Le Beau MM (1990): t(3;21) (q26;q22): A recurring chromosomal abnormality in therapy-related myelodysplastic syndrome and acute myeloid leukemia. Blood 76:2594-2598.
    • (1990) Blood , vol.76 , pp. 2594-2598
    • Rubin, C.M.1    Larson, R.A.2    Anastasi, J.3    Winter, J.N.4    Thangalevu, M.5    Vardiman, J.W.6    Rowley, J.D.7    Le Beau, M.M.8
  • 11
    • 0025046596 scopus 로고
    • Chromosome aberrations and prognostic factors in therapy-related myelodysplasia and acute nonlymphocyutic leukemia
    • Pedersen-Bjergaard J, Philip P, Larsen SO, Lensen G, Brysting K (1990): Chromosome aberrations and prognostic factors in therapy-related myelodysplasia and acute nonlymphocyutic leukemia. Blood 76:1083-1091.
    • (1990) Blood , vol.76 , pp. 1083-1091
    • Pedersen-Bjergaard, J.1    Philip, P.2    Larsen, S.O.3    Lensen, G.4    Brysting, K.5
  • 12
    • 0027154575 scopus 로고
    • Secondary acute myeloid leukemia in children previously treated with alkylating agents, intercalating topoisomerase II inhibitors and irradiation
    • Sandoval C, Pui CH, Bowman LG, Heaton D, Hurwitz CA, Raimondi SC, Behm FG, Head DR (1993): Secondary acute myeloid leukemia in children previously treated with alkylating agents, intercalating topoisomerase II inhibitors and irradiation. J Clin Oncol 11:1039-1045.
    • (1993) J Clin Oncol , vol.11 , pp. 1039-1045
    • Sandoval, C.1    Pui, C.H.2    Bowman, L.G.3    Heaton, D.4    Hurwitz, C.A.5    Raimondi, S.C.6    Behm, F.G.7    Head, D.R.8
  • 13
    • 0027722155 scopus 로고
    • Therapy-related myelodysplasia and acute myeloid leukemia. Cytogenetic characteristics of 115 consecutive cases and risk in seven cohorts of patients treated intensively for malignant diseases in the Copenhagen series
    • Pedersen-Bjergaard J, Philip P, Larsen SO, Andersson M, Daugaard G, Ersbøll J, Hansen SW, Hou-Jensen K, Nielsen D, Sigsgaard TC, Specht L, Østerlind K (1993): Therapy-related myelodysplasia and acute myeloid leukemia. Cytogenetic characteristics of 115 consecutive cases and risk in seven cohorts of patients treated intensively for malignant diseases in the Copenhagen series. Leukemia 7:1975-1986.
    • (1993) Leukemia , vol.7 , pp. 1975-1986
    • Pedersen-Bjergaard, J.1    Philip, P.2    Larsen, S.O.3    Andersson, M.4    Daugaard, G.5    Ersbøll, J.6    Hansen, S.W.7    Hou-Jensen, K.8    Nielsen, D.9    Sigsgaard, T.C.10    Specht, L.11    Østerlind, K.12
  • 15
    • 0028837972 scopus 로고
    • An acute myeloid leukemia gene, AML1, regulates hemopoietic myeloid cell differentiation and transcriptional activation antagonistically by two alternative spliced forms
    • Tanaka T, Tanaka K, Ogawa S, Kurokawa M, Mitani K, Nishida J, Shibata Y, Yazaki Y, Hirai H (1995): An acute myeloid leukemia gene, AML1, regulates hemopoietic myeloid cell differentiation and transcriptional activation antagonistically by two alternative spliced forms. EMBO J 14:341-350.
    • (1995) EMBO J , vol.14 , pp. 341-350
    • Tanaka, T.1    Tanaka, K.2    Ogawa, S.3    Kurokawa, M.4    Mitani, K.5    Nishida, J.6    Shibata, Y.7    Yazaki, Y.8    Hirai, H.9


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.